We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MHRA Offers Tips on Handling Suspected Quality Defects
MHRA Offers Tips on Handling Suspected Quality Defects
The UK’s Medicines and Healthcare products Regulatory Agency has released a guide for drugmakers on how to differentiate between defects, errors and adverse drug reactions and what to do when quality defects are suspected.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor